Connection

David Potter to Adrenergic alpha-Antagonists

This is a "connection" page, showing publications David Potter has written about Adrenergic alpha-Antagonists.
Connection Strength

0.471
  1. Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors. Exp Eye Res. 2001 Mar; 72(3):331-9.
    View in: PubMed
    Score: 0.179
  2. The central effects of moxonidine on intraocular pressure and its antagonism by L-659, 066 and L-657, 743 in the rabbit. Prog Neuropsychopharmacol Biol Psychiatry. 1994 Oct; 18(6):1051-61.
    View in: PubMed
    Score: 0.115
  3. Pharmacological evidence of a role for prejunctional imidazoline (I(1)) receptors in ocular function. Curr Eye Res. 2002 Nov; 25(5):267-70.
    View in: PubMed
    Score: 0.050
  4. Central imidazoline (I(1)) receptors modulate aqueous hydrodynamics. Curr Eye Res. 2001 May; 22(5):358-66.
    View in: PubMed
    Score: 0.045
  5. Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors. Curr Eye Res. 1996 Sep; 15(9):943-50.
    View in: PubMed
    Score: 0.033
  6. Pharmacological evidence for heterogeneity of ocular alpha 2 adrenoceptors. Curr Eye Res. 1992 Oct; 11(10):963-70.
    View in: PubMed
    Score: 0.025
  7. Medetomidine-induced alterations of intraocular pressure and contraction of the nictitating membrane. Invest Ophthalmol Vis Sci. 1991 Sep; 32(10):2799-805.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.